Not surprisingly, CA exhibited a considerable ability to mitigate obesity (Figure 3K; Figure S3J–M, Supporting Information), activate FXR, and modulate the expression of inflammation‐related genes (Figure 3L). Here, NR1H4 is linked to obesity disorder.